<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00947869</url>
  </required_header>
  <id_info>
    <org_study_id>DFG-SFB539-H</org_study_id>
    <nct_id>NCT00947869</nct_id>
  </id_info>
  <brief_title>Contrast Sensitivity in Glaucoma</brief_title>
  <official_title>Glaucoma Including Pseudoexfoliation Syndrome (SFB 539)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <brief_summary>
    <textblock>
      The primary aim of the Erlangen´s Glaucoma Contrast Sensitivity-Study (EGCS-Study) is the
      evaluation of the diagnostic and prognostic validity of a diagnostic procedure, measuring
      contrast sensitivity. No therapeutic studies are performed.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2009</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Primary Open Angle Glaucoma</condition>
  <condition>Secondary Open Angle Glaucoma Due to PEX</condition>
  <eligibility>
    <study_pop>
      <textblock>
        primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  Patients: Primary open angle glaucoma, secondary open angle glaucoma due to PEX

          -  Healthy volunteers (for reliability analysis)

        Inclusion Criteria:

          -  Age &gt; 18

          -  Best corrected visual acuity 0.8 or better

          -  European

        Exclusion Criteria:

          -  eye diseases: Infantile glaucoma, angle glaucoma, secondary open angle glaucoma, wich
             are not due to PEX, diseases involving retina, condition after ophthalmological
             operations or trauma, cataract, diseases concerning the refractive system, age-related
             macular degeneration, diabetic retinopathy, optic neuropathy (MS, neuritis), amblyopia

          -  Any neurological diseases

          -  Systemic diseases with potentially ocular involvement (e.g., diabetes mellitus)

          -  Systemic drugs with potentially ocular involvement

          -  ocular drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anselm G Juenemann, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>University Erlangen-Nuremberg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anselm G Juenemann, Prof.</last_name>
    <email>anselm.juenemann@uk-erlangen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Eye Hospital</name>
      <address>
        <city>Erlangen</city>
        <state>Bavaria</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hohberger</last_name>
      <phone>**49-9131-8534521</phone>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 27, 2009</study_first_submitted>
  <study_first_submitted_qc>July 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2009</study_first_posted>
  <last_update_submitted>July 27, 2009</last_update_submitted>
  <last_update_submitted_qc>July 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2009</last_update_posted>
  <responsible_party>
    <name_title>University Eye Hospital Erlangen</name_title>
    <organization>University of Erlangen-Nürnberg</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

